611 MYLAN
Pill imprint 611 MYLAN has been identified as Methyldopa 250 mg.
Methyldopa is used in the treatment of hypertensive emergency; high blood pressure and belongs to the drug class antiadrenergic agents, centrally acting. Risk cannot be ruled out during pregnancy.
Methyldopa 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Methyldopa Images
- Imprint:
-
611
MYLAN - Strength:
- 250 mg
- Color:
- Beige
- Size:
- 11.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide colloidal
croscarmellose sodium
hypromellose
magnesium stearate
microcrystalline cellulose
polydextrose
polyethylene glycol
sodium lauryl sulfate
titanium dioxide
triacetin
FD&C Yellow No. 6 Aluminum Lake
FD&C Blue No. 2 Aluminium Lake
- Drug Class:
- Antiadrenergic agents, centrally acting
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-0611
| NDC Code | Manufacturer / Repackager |
|---|---|
| 51079-0200 | UDL Laboratories Inc |
| 54569-0508 | A S Medication Solutions LLC (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Methyldopa resources
- Methyldopa (Wolters Kluwer)
- Methyldopate (Wolters Kluwer)
- methyldopa (Cerner Multum)
- methyldopa Oral, Intravenous (Micromedex) - Includes Dosage Information
- Methyldopa (AHFS DI)
- methyldopate hydrochloride (AHFS DI)
- Methyldopa (FDA)
- Methyldopate (FDA)
- Methyldopa and Methyldopate Hydrochloride (Wolters Kluwer)
Search Again
